SEC Filing Document

Company: DUKE Robotics Corp.
Ticker: DUKR
CIK: 1638911
Filing Type: DRS
Document Type: DRS
Date Filed: 2025-12-22
Accession Number: 0001213900-25-124553
Exchange: OTC
SIC Code: 3721
SIC Description: Aircraft
URL: https://www.sec.gov/Archives/edgar/data/1638911/000121390025124553/filename1.htm

Chunk 3 of 51
Word Count: 1493
Character Count: 9306

Document Content:

our listing application is approved, we expect to list our common stock on Nasdaq upon consummation of this offering, at which point our common stock will cease to be traded on the OTCQB Market. No assurance can be given that our listing application will be approved. This offering will only be consummated if Nasdaq approves the listing of our common stock and warrants. Nasdaq listing requirements include, among other things, a stock price threshold. As a result, prior to effectiveness, we intend to take the necessary steps to meet Nasdaq listing requirements, including but not limited to a consummating a reverse split of our outstanding common stock as further discussed below. If Nasdaq does not approve the listing of our common stock and warrants, we will not proceed with this offering. There can be no assurance that our common stock and warrants will be listed on Nasdaq. Reverse Stock Split

We expect to effect
a [   ]-for-[   ] reverse stock split of our outstanding common stock following the effective time of the registration statement of which
this prospectus forms a part but prior to the closing of this offering. We intend for the Board to effect such reverse stock split in
connection with the consummation of this offering and our intended listing of our common stock on Nasdaq, however we cannot guarantee
that such reverse stock split will be necessary or will occur in connection with the listing of our common stock on Nasdaq, or that Nasdaq
will approve our initial listing application for our common stock upon such reverse stock split.

The reverse stock
split will not impact the number of authorized shares of common stock which will remain at 350,000,000 shares. Unless otherwise noted,
the share and per share information in this prospectus reflects, other than in our financial statements and the notes thereto, a proposed
reverse stock split of the outstanding common stock and treasury stock of the Company at a [   ] ratio to occur immediately following the
effective time of the registration statement of which this prospectus forms a part but prior to the closing of this offering.

Corporate Information

We were founded in
2014 as UAS LLP. We are a Nevada corporation operating under the name DUKE Robotics Corp. (formerly UAS Drone Corp.). Our principal executive
offices are located at 10 HaRimon Street, Mevo Carmel Science and Industry Park, Israel, 2069203. Our corporate telephone number is +972-054-5707050.
Our website address is https://dukeroboticsys.com. We have not incorporated by reference into this prospectus, or the registration statement
to which this prospectus forms a part, the information included on or linked from our website and you should not consider it to be part
of this prospectus or the registration statement.

Risk Factors Summary

We are subject to
various risks discussed in detail under “Risk Factors,” which include risks related to the following:

●	We have a limited operating history and have generated limited revenues to date;

●	We may not be able to obtain adequate financing to continue our operations;

●	A substantial portion of our expected revenues is subject to Israeli
export control regulations, and any failure to obtain or maintain required approvals or licenses could materially and adversely affect
our business, results of operations and financial condition;

●	We have inadequate capital and need for additional financing to accomplish our business
and strategic plans. Terms of subsequent financing, if any, may adversely impact your investment;

●	Our revenues will depend heavily on government contracts;

●	Significant changes or developments in U.S. laws or policies, including changes in
U.S. trade policies and tariffs and the reaction of other countries thereto, may have a material adverse effect on our business and financial
statements;

●	We face other risks in our expected international sales;

●	We may experience production delays if suppliers fail to make compliant or timely
deliveries;

●	If we fail to manage growth or to prepare for product scalability effectively, it
could have an adverse effect on our employee efficiency, product quality, working capital levels and results of operations;

●	We were granted a patent for certain of our key technologies and may apply for additional
patents in the future. Our ability to protect our intellectual property and proprietary technology is uncertain and may be inadequate,
which may have a material and adverse effect on us;

●	We may become subject to claims of infringement or misappropriation of the intellectual
property rights of others, which could prohibit us from developing our products, require us to obtain licenses from third parties or to
develop non-infringing alternatives and subject us to substantial monetary damages;

●	We believe our current cash on hand will
not be sufficient to fund our projected operating requirements for a period of twelve months from the issuance of our third quarter financial
statements. This raises substantial doubt about our ability to continue as a going concern;

●	Our executive officer, directors and certain stockholders who are beneficial owners
of more than 5% of our outstanding common shares possess the majority of our voting power, and through this ownership, have the ability
to control our Company and our corporate actions;

●	Challenges in attracting analyst coverage and institutional investor
interest due to the way we originally became a public company;

●	There is a substantial lack of liquidity of our common stock and volatility risks;

●	Our common stock is subject to price volatility unrelated to us or our operations;

●	Sales of a substantial number of shares of our common stock, including
shares that may be issued upon the exercise or conversion of outstanding securities or become freely tradable under Rule 144 could cause
the market price of our common stock to decline;

●	Our financial position raises substantial doubt about our ability to continue as a
going concern;

●	We do not plan to declare or pay any dividends to our stockholders in the near future;

●	“Penny Stock” rules may make buying or selling our common stock difficult;

●	The sales practice requirements of FINRA may also limit a stockholder’s ability
to buy and sell our stock;

●	Our principal executive offices and other significant operations are located in Israel,
and, therefore, our results may be adversely affected by political, economic and military instability in Israel, including attacks by
Hamas and other terrorist organizations;

●	Our operations are subject to currency and interest rate fluctuations;

●	It may be difficult to enforce a judgment of a United States court against us and
our officers and directors to assert United States securities laws claims in Israel or to serve process on our officers and directors
and these experts;

●	Our operations may be disrupted as a result of the obligation of management or key
personnel to perform military service;

●	the dilution of our shares as a result of the issuance of additional shares in connection
with financing arrangements;

●	the decline in the price of our stock due to offers or sales of substantial number
of shares;

●	the limited trading volume and price fluctuations of our stock;

●	the immediate and substantial dilution of the net tangible book value of our common
stock;

●	the speculative nature of warrants;

●	provisions of the warrants may discourage a third-party from acquiring us;

●	our ability to meet the initial or continuing Nasdaq listing requirements;

●	the reverse stock split we intend to effect may not increase our stock price sufficiently
and we may not be able to list our common stock on Nasdaq in which case this offering may not be consummated;

●	We operate in a competitive industry;

●	Undetected defects or malfunctions in our products could impair our financial results, harm our reputation, and expose us to significant product liability claims that may not be adequately covered by insurance;

●	Our business depends on proprietary technology that may be infringed;

●	We rely on highly skilled personnel and, if we are unable to retain or motivate key
personnel or hire additional qualified personnel, we may not be able to grow effectively;

●	Our management team may not be able to successfully implement our business strategies;

●	Significant disruptions of our information technology systems or breaches of our data
security could adversely affect our business;

●	A decline in the price of our common stock could affect our ability to raise working
capital and adversely impact our ability to continue operations;

●	The requirements of being a public company may strain our resources and distract management;

●	Future changes in financial accounting standards or practices may cause adverse
unexpected financial reporting fluctuations and affect reported results of operations.

Please see “Risk
Factors” beginning on page 9 for a more detailed discussion of these risks. Additional risks, beyond those summarized above or
discussed under the caption “Risk Factors” or described elsewhere in this prospectus may also materially and adversely impact
our business, operations or financial results.

Summary
of the Offering

Issuer:	DUKE Robotics Corp.